Systemic effects of oral budesonide in hematopoietic transplant: implications of drug interaction with azoles.
R
R
El Fakih
G A
GA
Obi
A
A
Scholoff
G
G
Carrum
R T
RT
Kamble
D000284:Administration, Oral; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects; D001393:Azoles / Q000008:administration & dosage / Q000009:adverse effects; D019819:Budesonide / Q000008:administration & dosage / Q000009:adverse effects; D003480:Cushing Syndrome / Q000097:blood / Q000139:chemically induced*; D004347:Drug Interactions; D005260:Female; D005767:Gastrointestinal Diseases / Q000097:blood / Q000188:drug therapy; D006086:Graft vs Host Disease / Q000097:blood / Q000188:drug therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007049:Iatrogenic Disease; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000628:therapy; D008297:Male; D008875:Middle Aged; D014184:Transplantation, Homologous
D000893:Anti-Inflammatory Agents; D001393:Azoles; D019819:Budesonide